NMIBC—BCG Strain and Outcomes
BCG is an immunotherapy. There are at least 4 different strains, Connaught, Pasteur, Tice, RIVM Whether the commonly used Bacillus Calmette-Guérin (BCG) strains Connaught and Tice confer different outcomes is questionable. This chapter covers BCG strains and outcomes.
- Farah NB, Ghanem R, Amr M. Treatment efficacy and tolerability of intravesical Bacillus Calmette-Guerin (BCG)-RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC). BMC Urol. 2014;14:11.Google Scholar
- Witjes JA, Dalbagni G, Karnes RJ, Shariat S, Joniau S, Palou J, Serretta V, Larré S, di Stasi S, Colombo R, Babjuk M, Malmström PU, Malats N, Irani J, Baniel J, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Spahn M, Pisano F, Gontero P, Sylvester R. The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer. Urol Oncol. 2016;34(11):484.e19–25.CrossRefGoogle Scholar